研究者業績

熊谷 直憲

クマガイ ナオノリ  (Naonori Kumagai)

基本情報

所属
藤田医科大学 医学部 医学科 准教授
学位
医学博士(東北大学)

J-GLOBAL ID
200901049398635563
researchmap会員ID
6000015448

外部リンク

論文

 89
  • Michiaki Abe, Kazuhiko Kawaguchi, Satomi Yamasaki, Toshiki Nakai, Masaharu Hatachi, Takanori Mizuno, Atsuko Masaura, Naonori Kumagai, Tadashi Ishii
    PloS one 21(1) e0339198 2026年  査読有り
    Citrate supplementation is well known to alleviate muscle fatigue. Furthermore, our previous clinical study revealed that citrate supplementation prevents renal oxidative stress and dysfunction. We hypothesize that an interaction between muscle and kidney tissues underlies the effects of citrate supplementation. This study investigated the effects of a citrate agent, potassium citrate/sodium citrate (PCSC), on muscle and renal functions. Male Sprague-Dawley rats were randomly assigned to two groups (control and PCSC groups). PCSC (2000 mg/kg body weight) was administered orally administrated for one week. Kidney weight, vastus lateralis muscle weight, and renal function were compared between the groups. Subsequently, the kidney and muscle tissues were analyzed using metabolomics. The PCSC group showed a significant increase in muscle mass relative to the weight gain (p = 0.0472). Renal function development with growth was more pronounced in the PCSC group (p < 0.0001). Metabolomic analysis of muscle tissue in the PCSC group revealed increased alanine levels and decreased levels of sarcosine, creatinine, and NADPH/NADP+ ratio. In the kidney tissue, PCSC supplementation led to elevated N,N-dimethylglycine, urea, and the ratio of malic acid to aspartate, while betaine aldehyde, carnitine, and Fisher's ratio decreased. The study concluded that PCSC supplement facilitated muscle growth metabolically through an alanine-associated pathway and renal function development by increasing intrarenal urea and accelerating the malate-shuttle and the betaine pathway. These findings indicate PCSC's potential impact of PCSCs on muscle-kidney interactions.
  • Tomomi Kondoh, Takuma Ando, Yuji Matsumoto, Naonori Kumagai, Yu Tanaka, Naoya Morisada, Kandai Nozu, Yohei Ikezumi
    Human genome variation 12(1) 28-28 2025年11月22日  査読有り
  • Naonori Kumagai, Takuma Ando, Tomomi Kondoh, Yuji Matsumoto, Michiaki Abe, Yohei Ikezumi
    2025年9月2日  筆頭著者責任著者
  • Kumagai N, Akamatsu M, Kawamura Y, Mizuno H, Ikezumi Y
    Cureus 2025年1月14日  査読有り筆頭著者責任著者
    We report a case of tubulointerstitial nephritis with uveitis (TINU) diagnosed from isolated glucosuria detected during school urinary screening. The patient was a 12-year-old girl in whom glucosuria was detected during school urinary screening using a dipstick; however, urinary protein and occult blood were negative. There were no preceding symptoms of infection or medication. The patient visited the Fujita Health University Okazaki Medical Center two weeks after the school urinary screening for further examination. No edema or skin rash was observed. A urine test showed urinary glucose was positive and urinary β2-microglobulin was high; other values were almost normal. Mild renal dysfunction was observed. There was no hyperglycemia or high HbA1c level; therefore, diabetes mellitus was ruled out. Various autoantibody tests were negative, and the angiotensinogen-converting enzyme level was within the normal range. The patient was clinically diagnosed with idiopathic tubulointerstitial nephritis without a renal biopsy. Renal dysfunction tended to improve gradually after the first visit. Three months after the first visit, conjunctival congestion appeared in the right eye, and the patient was diagnosed with uveitis and eventually with TINU. When performing detailed examinations for urinary glucose, it is necessary to differentiate kidney disease as well as diabetes mellitus. Moreover, it is necessary to recognize that even if the urine dipstick test is negative for protein, it may be positive for low-molecular-weight protein.
  • Naonori Kumagai, Hiroki Takao, Yuta Sudo, Masatoshi Yoshikane, Tomomi Kondoh, Yuji Matsumoto, Haruo Mizuno, Michiaki Abe, Yohei Ikezumi
    Diabetology & Metabolic Syndrome 2024年11月20日  査読有り筆頭著者責任著者

MISC

 191

講演・口頭発表等

 76

共同研究・競争的資金等の研究課題

 5

社会貢献活動

 1